COLUMBIA UNIVERSITY TRAINED JOHNS HOPKINS TRAINED BOARD CERTIFIED PMHNP
GARDEN CITY OFFICE
Concierge Psychiatric Care
for High-Stakes Professionals
COLUMBIA UNIVERSITY TRAINED JOHNS HOPKINS TRAINED BOARD CERTIFIED PMHNP
GARDEN CITY OFFICE
Concierge Psychiatric Care
for High-Stakes Professionals
— Clinical Program
Clinical Indicators — SEP
The SEP Profile
The Stressed Executive and Professional presents a distinct clinical picture. The symptoms are real and measurable. But they exist within an occupational context that most psychiatric providers have never inhabited and cannot therefore adequately assess.
The occupational environment is not incidental to the clinical picture. It is central to it. The zero-failure demands of legal practice. The high-frequency decision-making of finance. The isolation and visibility of executive leadership. These are not background stressors they are the primary clinical inputs.
The SEP program addresses this directly. It is structured around the reality that your professional environment is not something to be managed around it is something to be clinically understood and incorporated into a precise treatment framework.
Not subjectively, objectively, Output, decision quality, or interpersonal function has shifted in ways you or others have noticed.
You need a provider who can assess your presentation within the specific demands of your occupational environment not one who needs that environment explained.
Strategic Clinical Planning Roadmap
Stage 01
A 60-minute initial consultation structured as a clinical interview. Full psychiatric history. Occupational context the specific demands, pressures, and consequences of your professional environment. Current symptom profile. Previous treatment history and outcomes.
Stage 02
Differential diagnosis across the relevant clinical categories. Pharmacogenomic testing where biologically indicated to assess metabolic pathways, receptor sensitivity, and medication compatibility at the genetic level. Occupational stress mapping to identify the specific intersection of professional demands and psychiatric presentation.
Stage 03
Stage 04
Structured follow-up at clinically appropriate intervals. Treatment plan adjusted as your presentation evolves, your occupational context shifts, or new clinical data warrants reconsideration. Direct access to Brad between sessions when clinically indicated. The treatment relationship does not end at the prescription it continues for as long as the clinical situation requires.
What Distinguishes This Approach
The JD is not decorative. Legal training produces a particular cognitive discipline the capacity to hold competing hypotheses simultaneously, to weigh evidence without premature closure, to identify the exact point at which a conclusion is and is not supported by the available facts.
Applied to psychiatric practice, this means a diagnostic process that is genuinely rigorous not pattern-matching to the most common presentation, but building a clinical case from the available evidence. It means a treatment plan that can withstand scrutiny. It means a provider who will tell you what the data supports, and what it does not.
My practice is unapologetically analytical. I investigate root causes, not just symptoms. I build a clinical case the same way I once built a legal one from the evidence, to the conclusion, without shortcutting the middle.
— Brad Lieberman, JD, MSN, PMHNP-BC
Clinical Focus Areas — SEP
Each of the following is assessed in the context of your specific occupational environment not in isolation from it.
01
02
03
Sustained cognitive impairment, decision fatigue, and working memory disruption under high occupational load with clinical differentiation from ADHD, mood disorders, and stress-related presentations.
04
Anhedonia, persistent low mood, and motivational collapse in individuals who continue to function externally at a high level a presentation systematically underdiagnosed in professional populations.
05
Chronic sleep disruption assessed in the context of occupational stress, anxiety, depression, and biological factors with pharmacological and integrated treatment approaches where indicated.
06